Bastion Therapeutics Company Profile, Contacts & Intelligence

Biotechnology ResearchSpace, United Kingdom3 employees
Employees
3
Company source estimate

Bastion Therapeutics Overview

Bastion Therapeutics was a biotech co-founded by Nia Emami. Our mission was to develop novel Treg cell therapies for inflammatory disorders with high unmet need. We used our proprietary GRIT™ platform to engineer Tregs that modulate the immune system and overcome key limitations of earlier approaches. Our goal was to create therapies that are safe, durable, and truly effective for patients. Bastion Therapeutics concluded operations in December 2024.

Headquarters
Space, United Kingdom
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

Bastion Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Bastion Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Bastion Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Quell Therapeutics Biotechnology Research 151 View company
Sonoma Biotherapeutics, Inc. Biotechnology Research 117 View company
Resilient Collective Business Consulting And Services 90 View company
GentiBio Biotechnology 52 View company
Cellenkos, Inc. Biotechnology 16 View company
Coya Therapeutics, Inc. Biotechnology Research 14 View company
Celentyx Ltd Biotechnology Research 13 View company
Mesenbio Biotechnology Research 10 View company
Abata Therapeutics Biotechnology Research 7 View company
Senya Therapeutics Biotechnology Research 7 View company